C₂N Diagnostics is a specialty diagnostics company with a vision to bring Clarity Through Innovation®.
- Tweets 336
- Following 210
- Followers 296
- Likes 87
Pinned Tweet
C2N Diagnostics, used in clinical trials for #Leqembi™ for #Alzheimer’s disease treatment, poised to support medical community in next steps. Health care providers begin to register to use C2N’s analytically & clinically validated blood tests. #FDA businesswire.com/news/home/2…
1
3
541
C2N announces partnership w/ @MichaelJFoxOrg to uncover new links b/w #ParkinsonsDisease #LewyBodyDementia & #AlzheimersDisease c2n.com/news-releases/c2n-di…
130
C2N Diagnostics retweeted
Announcing a new DxA investment in @C2NDiagnostics for over $7M—its largest investment to-date. This underscores the DxA’s commitment to developing & deploying #novel biomarkers—like #BloodTests—to transform the #Alzheimers diagnostic landscape: bit.ly/3TGx8yu
1
2
5
460
C2N Diagnostics has entered into a non-exclusive agreement in select markets w/ @mayocliniclabs for inclusion of C2N’s Precivity™ tests in their test offerings. bit.ly/3XGmZo7#liquidbiopsie… #precisionmedicine #Alzheimersdisease #MayoClinicLaboratories
165
C2N Diagnostics retweeted
Hats off to our supporters/sponsors/grantors: @MeilleurTechnologies, @LantheusNews, @EliLillyandCo, @alzassociation, @eisaiusneuro, @genentech, @RCFNeuro, @bmsnews, @Invicro, @LifeMolecular, @JNJNews, @C2NDiagnostics, @Clario, @abbvie, @QuanterixSimoa Big round of applause
1
11
1,817
Allston Brighton Community Fund is proud to support @ablittleleague.
For over 70 years, the Allston Brighton Little League has been part of our community. We can’t wait to hear “play ball!”
#baseball #littleleague #AllstonBrighton
leaguelineup.com/welcome.asp…
1
1
165
Researchers identify new cost savings and accuracy of C₂N Diagnostics’ blood tests to enable healthcare providers to better identify Alzheimer’s disease.
#CTAD23 c2n.com/news-releases/resear…
132
C2N Sr. Medical Advisor Dr. Monane will present his research @geronsociety #GSA2023 in Tampa. "Patient Age And Sex Do Not Appear To Influence Decision Making Around Biomarker Testing for Cognitive Impairment.” Session 9550: 11/12, 10:00–11:30 a.m. room 413 #GSA2023 #Alzheimers
2
260
C2N Diagnostics retweeted
Congratulations to @RandallBateman3 our CTAD Lifetime Achievement Award recipient in recognition for his pioneering work in Alzheimer's Disease Research and Plasma Biomarkers in AD diagnostics.
1
5
33
2,341
Congrats to our scientific co-founder @RandallBateman3 on receiving the @CTADconference Lifetime Achievement Award in recognition of his pioneering work in Alzheimer’s disease research and plasma biomarkers in AD diagnosis. #CTAD2023
2
4
581
C2N Diagnostics introduces next-generation fluid biomarker to the field of #Alzheimer’s disease: Test to help researchers track neurofibrillary “tau” tangle pathology. #CTAD2023 c2n.com/news-releases/cn-dia…
1
129
C2N Diagnostics retweeted
advancements, expansion
~@GenScript expands reagent services, adds #CircularRNA, #LipidNanoparticles formulation
~On #WorldAlzheimersDay, @C2NDiagnostics expands #bloodtest reach
~@viz_ai expands #outpatient ambulatory centers to advance trial recruitment in #HeartFailure
ALT Image Source: Fierce Biotech
1
2
137
On #worldalzheimersday2023, C₂N Diagnostics’ PrecivityAD2™ blood test expands reach. The test availability through Grupo Fleury aims to help #Brazilians receive accurate, early #AlzheimersDisease #diagnosis c2n.com/news-releases/on-wor… #Brazil
1,209
News from @medicaldevnet about the PrecivityAD2™ blood test that aims to set a new performance standard for blood biomarkers in #Alzheimer’s disease diagnosis w/ combined measures of amyloid beta (aβ42/40) & tau protein (p-tau217/np-tau217) ratios
medicaldevice-network.com/ne…
4
224
.@adnewstoday reports on study published in @ANA_journals that shows the PrecivityAD® blood test significantly influences clinicians’ decisions about whether to treat people with cognitive impairments for #Alzheimer’s disease. alzheimersnewstoday.com/news…
1
120
.@FierceBiotech reports on our release of the PrecivityAD2™ blood test for clinical care, a robust #assay w/ high concordance to amyloid PET & CSF fiercebiotech.com/medtech/c2…
#AlzheimersDisease
1
92
C₂N Diagnostics Releases the PrecivityAD2™ Blood Test for Clinical Care, a Robust Assay with High Concordance to Amyloid PET and CSF
#test #Alzheimer #dementia
precivityad.com/news/cn-diag…
3
2
522
C2N Diagnostics retweeted
#clinicaldata
~@Masimo SedLine could improve #brain monitoring during #endoscopy, study says
~@spinex_official's #neuromodulation #tech ‘game-changing’ for children with #cerebralpalsy
~#RWE shows promise for @C2NDiagnostics' PrecivityAD® #BloodTest
ALT Image Source: https://www.fiercebiotech.com/medtech/c2ns-amyloid-and-tau-detecting-alzheimers-blood-test-outperforms-other-screening-tools-2
1
1
112
C2N Diagnostics retweeted
New real-world evidence released by ADDF-funded @C2NDiagnostics shows that their PrecivityAD2 beta-amyloid #BloodTest helped correctly diagnose #Alzheimers in 87% of cases as compared to using standard assessment tools. Read more about the findings here: bit.ly/3YrEoiS
2
2
365